Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $70.74, but opened at $73.64. Sandoz Group shares last traded at $71.9995, with a volume of 969 shares traded.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on SDZNY shares. Barclays raised Sandoz Group to a “strong-buy” rating in a research report on Monday, October 13th. Jefferies Financial Group lowered Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Sandoz Group currently has a consensus rating of “Moderate Buy”.
Read Our Latest Analysis on Sandoz Group
Sandoz Group Trading Up 1.4%
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Further Reading
- Five stocks we like better than Sandoz Group
- Investing in Construction Stocks
- Will Crypto Miners Pivot to AI? Latest on 3 Key Players
- 3 Best Fintech Stocks for a Portfolio Boost
- Salesforce Stock Is Coiled Like a Spring and Ready to Rebound
- How to invest in marijuana stocks in 7 stepsĀ
- Marvell’s Rally Extends: Data Centers and AMZN Chips Boost Shares
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
